Focused on building companies through early-stage, opportunistic, and diversified investments in the cannabis space Spun off from Aurora Cannabis in late 2018 Terry Booth, who helped build Aurora, now CEO What Australis Capital does:
The Nevada-based company’s business and assets include investments in Cocoon Technology LLC, Body and Mind Inc, Green Therapeutics LLC, Quality Green, Folium Biosciences, and land assets in Washington state and Michigan.
Australis was spun out from cannabis behemoth Aurora Cannabis Inc (TSE:ACB) (NYSE:ACB) in September 2018 as its US investment vehicle. Aurora is not allowed to invest in US cannabis assets due to Toronto Stock Exchange and NYSE listing rules. Australis is therefore Aurora’s arm to establish a foothold in the US, before a potential US federal legalization shift.
As part of the new strategy to scale up its award-winning brands across the US and global cannabis markets, the company has acquired a 51% interest in cash-flow-healthy ALPS – the world’s premier design, construction management, commissioning, and post-commissioning consultancy for horticultural crops such as cannabis.
Australis has also gone through the process of acquiring a 100% interest of the outstanding membership interest in Nevada-based cannabis cultivator Green Therapeutics.
But the ALPS acquisition is central to the company’s growth blueprint, and as such, former Aurora CEO Terry Booth is now Australis’ new CEO, taking over from Duke Fu, who had been serving as Interim CEO since November 2020. Fu now is COO, focusing on driving organic growth.
With a number of existing customer relationships and significant contracts, Australis said ALPS is expected to bring material revenues to the company and is also anticipated to be immediately accretive to the company’s results.
Australis plans to leverage ALPS’s customer relationships, whereby customers, in return for